These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6313904)

  • 21. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
    Asensio VJ; Miralles A; García-Sevilla JA
    Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
    McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine-6-glucuronide-induced locomotor stimulation in mice: role of opioid receptors.
    Grung M; Skurtveit S; Aasmundstad TA; Handal M; Alkana RL; Mørland J
    Pharmacol Toxicol; 1998 Jan; 82(1):3-10. PubMed ID: 9527644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New developments and findings in the field of opiates, opioids, opiate receptors and complete and partial opiate antagonists].
    Schneider M; Bunge HJ; Heinrich F
    Anaesthesiol Reanim; 1990; 15(3):138-44. PubMed ID: 2168183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo antagonism of analgesia and respiratory depression induced by proposed mu and kappa opiate agonists [proceedings].
    Metcalf G; Rees JM; Ward SJ
    Br J Pharmacol; 1979 Jul; 66(3):473P-474P. PubMed ID: 230881
    [No Abstract]   [Full Text] [Related]  

  • 26. [Four long-acting analgesic hydrazone derivatives of opiates which bind more firmly with opiate receptors].
    Li LY; Ye CY; Zhang ZR; Wang L; Jin YC
    Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):152-6. PubMed ID: 3017044
    [No Abstract]   [Full Text] [Related]  

  • 27. Simple in vivo tests that differentiate prototype agonists at opiate receptors.
    Cowan A
    Life Sci; 1981 Apr; 28(14):1559-70. PubMed ID: 6264252
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modulation of circadian rhythms of aggressive behavior and locomotor activity by opiate receptor agonists and antagonists in mice].
    Kubynin AN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(1):172-3. PubMed ID: 2837021
    [No Abstract]   [Full Text] [Related]  

  • 29. Dextro-naloxone counteracts amphetamine-induced hyperactivity.
    Chatterjie N; Sechzer JA; Lieberman KW; Alexander GJ
    Pharmacol Biochem Behav; 1998 Feb; 59(2):271-4. PubMed ID: 9476969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice.
    Taber RI; Greenhouse DD; Rendell JK; Irwin S
    J Pharmacol Exp Ther; 1969 Sep; 169(1):29-38. PubMed ID: 5804610
    [No Abstract]   [Full Text] [Related]  

  • 31. Receptors and post-receptors alterations induced by opiates and solubilization of opiate receptors.
    Simantov R; Baram D; Dornay M
    Adv Biochem Psychopharmacol; 1982; 33():291-300. PubMed ID: 6289626
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of "wet shakes" during morphine abstinence by an antagonist of opiate analgesia.
    Vetulani J; Bednarczyk B; Reichenberg K
    Eur J Pharmacol; 1978 Aug; 50(3):261-4. PubMed ID: 308460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Opiates and their antagonists].
    Langwiński R
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1625-9. PubMed ID: 6089154
    [No Abstract]   [Full Text] [Related]  

  • 34. 1989 Annual Report, evaluation of new compounds for opioid activity.
    Woods JH; Medzihradsky F; Smith CB; Winger GD; France CP
    NIDA Res Monogr; 1989; 95():632-79. PubMed ID: 2561858
    [No Abstract]   [Full Text] [Related]  

  • 35. History and development of mixed opioid agonists, partial agonists and antagonists.
    Martin WR
    Br J Clin Pharmacol; 1979; 7 Suppl 3(Suppl 3):273S-279S. PubMed ID: 380616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations.
    Loew GH; Berkowitz DS; Burt SK
    NIDA Res Monogr; 1978; (22):278-316. PubMed ID: 213725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of writhing and other effects of narcotics and narcotic antagonists in mice.
    Pearl J; Aceto MD; Harris LS
    J Pharmacol Exp Ther; 1968 Mar; 160(1):217-30. PubMed ID: 5639107
    [No Abstract]   [Full Text] [Related]  

  • 38. Opiates increase plasma catecholamines in humans.
    Hoehe M; Duka T
    Psychoneuroendocrinology; 1993; 18(2):141-8. PubMed ID: 8388112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role for endogenous opiates in incubation behavior in ring neck doves (Streptopelia risoria).
    Burns-Cusato M; Rieskamp J; Nagy M; Rana A; Hawkins W; Panting S
    Behav Brain Res; 2021 Feb; 399():113052. PubMed ID: 33279638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone potentiation of apomorphine-induced stereotypic climbing in mice and interaction with mu-, sigma- and kappa-opiate drugs.
    Quock RM
    Life Sci; 1982 Dec; 31(25):2907-11. PubMed ID: 6298534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.